Clinical trial
Safety and Tolerability of Escalating Doses of Subcutaneous Elafin (Tiprelestat) Injection in Healthy Normal Subjects
NCT03522935 is registered in ClinicalTrials.gov with Roham T. Zamanian as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Tolerability of Escalating Doses of Subcutaneous Elafin (Tiprelestat) Injection in Healthy Normal Subjects
- Lead sponsor
- Roham T. Zamanian
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 18, 2019
- Completion date
- November 18, 2020
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.